1. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882-893. doi:10.1016/S0140-6736(15)00067-7
2. Thornhill MH, Dayer MJ, Forde JM, et al. Impact of the NICE guidelinerecommending cessation of antibiotic prophylaxis for prevention ofinfective endocarditis: before and after study. BMJ. 2011;342:d2392.doi:10.1136/bmj.d2392
3. Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, ThornhillMH. Incidence of infective endocarditis in England, 2000-13: a seculartrend, interrupted time-series analysis. Lancet. 2015;385(9974):1219-1228. doi:10.1016/S0140-6736(14)62007-9
4. Thornhill MH, Jones S, Prendergast B, et al. Quantifying infectiveendocarditis risk in patients with predisposing cardiac conditions. EurHeart J. 2018;39(7):586-595. doi:10.1093/eurheartj/ehx655
5. Şimşek-Yavuz S, Akar AR, Aydoğdu S, et al. Diagnosis, treatment andprevention of infective endocarditis: Turkish consensus report-2019.İnfektif endokarditin tanısı, tedavisi ve önlenmesi: Ulusal uzlaşıraporu-2019. Turk Kardiyol Dern Ars. 2020;48(2):187-226. doi:10.5543/tkda.2020.89689
6. Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of viridansgroup streptococcal infective endocarditis: a scientific statement fromthe American Heart Association. Circulation. 2021;143(20):e963-e978.doi:10.1161/CIR.0000000000000969
7. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines forthe management of infective endocarditis: The Task Force for theManagement of Infective Endocarditis of the European Society ofCardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of NuclearMedicine (EANM). Eur Heart J. 2015;36(44):3075-3128. doi:10.1093/eurheartj/ehv319
8. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing anddental extraction. Circulation. 2008;117(24):3118-3125. doi:10.1161/CIRCULATIONAHA.107.758524
9. Veloso TR, Amiguet M, Rousson V, et al. Induction of experimentalendocarditis by continuous low-grade bacteremia mimickingspontaneous bacteremia in humans. Infect Immun. 2011;79(5):2006-2011. doi:10.1128/IAI.01208-10
10. Duval X, Alla F, Hoen B, et al. Estimated risk of endocarditis inadults with predisposing cardiac conditions undergoing dentalprocedures with or without antibiotic prophylaxis. Clin Infect Dis.2006;42(12):e102-e107. doi:10.1086/504385
11. Lee P, Shanson D. Results of a UK survey of fatal anaphylaxis after oralamoxicillin. J Antimicrob Chemother. 2007;60(5):1172-1173. doi:10.1093/jac/dkm315
12. Duval X, Leport C. Prophylaxis of infective endocarditis: currenttendencies, continuing controversies. Lancet Infect Dis. 2008;8(4):225-232. doi:10.1016/S1473-3099(08)70064-1
13. Bergadà-Pijuan J, Frank M, Boroumand S, et al. Antibiotic prophylaxisbefore dental procedures to prevent infective endocarditis: a systematicreview. Infection. 2023;51(1):47-59. doi:10.1007/s15010-022-01900-0
14. Rutherford SJ, Glenny AM, Roberts G, Hooper L, Worthington HV.Antibiotic prophylaxis for preventing bacterial endocarditis followingdental procedures. Cochrane Database Syst Rev. 2022;5(5):CD003813.doi:10.1002/14651858.CD003813.pub5
15. Dayer M, Thornhill M. Is antibiotic prophylaxis to prevent infectiveendocarditis worthwhile?. J Infect Chemother. 2018;24(1):18-24.doi:10.1016/j.jiac.2017.10.006
16. Sendi P, Hasse B, Frank M, et al. Infective endocarditis: prevention andantibiotic prophylaxis. Swiss Med Wkly. 2021;151:w20473. doi:10.4414/smw.2021.20473
17. Thornhill MH, Dayer MJ, Prendergast B, Baddour LM, Jones S, LockhartPB. Incidence and nature of adverse reactions to antibiotics used asendocarditis prophylaxis. J Antimicrob Chemother. 2015;70(8):2382-2388.doi:10.1093/jac/dkv115